Stockholders' Deficit (Additional Information) (Details)
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
12 Months Ended |
|
|
|
Dec. 11, 2025
$ / shares
shares
|
Nov. 23, 2025
USD ($)
$ / shares
shares
|
Sep. 30, 2025
USD ($)
$ / shares
shares
|
Dec. 26, 2024
USD ($)
|
Dec. 11, 2024
USD ($)
$ / shares
shares
|
Oct. 27, 2024
USD ($)
Days
$ / shares
shares
|
Sep. 20, 2024
USD ($)
|
Apr. 23, 2024
USD ($)
$ / shares
shares
|
Feb. 29, 2024
$ / shares
shares
|
Dec. 22, 2023
shares
|
Mar. 31, 2026
USD ($)
$ / shares
shares
|
Mar. 31, 2025
USD ($)
shares
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Mar. 02, 2026
$ / shares
|
Feb. 03, 2026
shares
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock Share Price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 630
|
|
|
|
|
| Stock-based compensation | $ |
|
|
|
|
|
|
|
|
|
|
$ 3,629,000
|
$ 3,314,000
|
|
|
|
| Additional paid-in capital | $ |
|
|
|
|
|
|
|
|
|
|
$ 799,301,000
|
|
$ 796,721,000
|
|
|
| Clearing expenses | $ |
|
|
|
|
|
|
|
$ 15,950,000
|
|
|
|
|
|
|
|
| Common stock, par value | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
$ 0.0001
|
$ 0.68
|
|
| Combined Price Paid | $ / shares |
|
|
|
|
|
|
|
|
$ 54.74
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
156,220
|
|
156,220
|
|
|
| Treasury Stock Common Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
1,458,263
|
|
1,458,263
|
|
|
| Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
3,250,000
|
|
3,250,000
|
|
|
| Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Legal fees and expenses | $ |
|
|
|
|
|
|
|
$ 100,000
|
|
|
|
|
|
|
|
| Cash fee percentage of gross proceeds paid to placement agents |
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
1,200,000
|
|
1,200,000
|
|
|
| Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percent of total number of shares issued to agents in the Offering |
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
| Series 1 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trading Days | Days |
|
|
|
|
|
10
|
|
|
|
|
|
|
|
|
|
| Preferred Stock, Dividends Per Share, Declared | $ / shares |
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
| Conversion of Stock, Amount Converted | $ |
|
|
|
|
|
$ 200,000,000
|
|
|
|
|
|
|
|
|
|
| Preferred Stock Dividends, Shares |
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
| Treasury Stock Common Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
5,000,000
|
| Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preference shares issue |
|
|
|
|
|
|
|
|
|
|
45,000,000
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
29,057,097
|
|
29,057,097
|
|
|
| Rodman & Renshaw LLC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public Offering Price | $ / shares |
|
|
|
|
|
|
|
|
59.5
|
|
|
|
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
|
|
|
|
$ 59.5
|
|
|
|
|
|
|
| Warrant Purchase |
|
|
|
|
|
|
|
|
168,068
|
|
|
|
|
|
|
| Common stock sold |
|
|
|
|
|
|
|
|
168,068
|
|
|
|
|
|
|
| At-the-Market Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceed's of sale of common shares |
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
| Common stock sold |
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
| Securities Purchase Agreement | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
|
|
|
|
|
|
|
34,286
|
|
|
|
|
|
|
|
| Securities Purchase Agreement | Common Stock [Member] | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Price per share (in Dollars per share) | $ / shares |
|
|
|
|
$ 20.65
|
|
|
$ 35
|
|
|
|
|
|
|
|
| Warrant Inducement Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Received in cash | $ |
|
$ 18,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Inducement Agreement | November 2025 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
$ 29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
$ 29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fair Value of the Fee Warrant | $ |
|
$ 6,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expiration date |
|
Nov. 25, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Purchase |
|
1,356,594
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Inducement Agreement | November 2025 Warrants [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 29
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 29
|
|
|
|
|
| Warrants exercisable |
|
|
|
|
|
|
|
|
|
|
1,428,946
|
|
|
|
|
| Warrant Purchase |
|
|
|
|
|
|
|
|
|
|
72,352
|
|
|
|
|
| Warrant Exercise Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
275,000
|
|
|
|
|
| Warrant Exercise Agreement | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number Of Share Outstanding |
|
|
4.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
|
|
|
|
|
|
|
|
|
|
275,000
|
|
|
|
|
| Deferral fee | $ |
|
|
$ 2,700,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Exercise Agreement | New Tranche B Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrant | $ / shares |
|
|
$ 20
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Purchase |
|
|
275,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from sale of common stock | $ |
|
|
$ 2,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Exercise Agreement | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
|
$ 22.72
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
|
$ 22.72
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
|
|
179,236
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferral fee per share | $ / shares |
|
|
$ 7.72
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value | $ / shares |
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity Purchase Agreements | November 2025 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant Purchase |
|
|
|
|
|
|
|
|
|
|
1,356,594
|
|
|
|
|
| Repricing Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,400,000
|
|
|
| Recognized incremental stock-based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,700,000
|
|
|
| Reduction in the exercise prices | $ / shares |
$ 16.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Unrecognized incremental stock-based compensation expense | $ |
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
| Maximum | Series 1 Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trading Days | Days |
|
|
|
|
|
15
|
|
|
|
|
|
|
|
|
|
| Maximum | At-the-Market Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of Common Stock Shares Issued |
|
|
|
|
|
|
|
|
|
170,000,000
|
|
|
|
|
|
| Maximum | Warrant Exercise Agreement | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number Of Share Outstanding |
|
|
9.99%
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other Noncurrent Liabilities | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital | $ |
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
| Public Warrants Purchase Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 402.5
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 402.5
|
|
|
|
|
| 2022 Equity Incentive Plan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
282.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised price | $ / shares |
282.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares reserved for future issuance |
|
|
|
|
|
|
|
|
|
|
1,051,604
|
|
|
|
|
| 2022 Equity Incentive Plan | Repricing Options |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
282.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercised price | $ / shares |
$ 282.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
289,405
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Representative Warrants Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
470,588
|
|
|
| Representative Warrants Outstanding | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
13,446
|
|
|
| Representative Warrants Outstanding | Other Noncurrent Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital | $ |
|
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Firm Warrants [Member] | Securities Purchase Agreement | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number Of Warrants Exercised |
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
| Number Of Warrants Exercised |
|
|
|
|
|
|
|
|
|
|
3,803,447
|
|
108,686
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
$ 20.65
|
|
|
|
|
|
|
|
|
|
|
| Warrant Purchase |
|
|
|
|
50,421
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrant exercises | $ |
|
|
|
$ 200,000
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
|
|
|
$ 38.5
|
|
|
|
|
|
|
|
| Registered Direct Offering | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
|
|
|
|
1,642,871
|
|
|
|
|
|
537,298
|
|
131,472
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
537,298
|
|
|
|
|
| Registered Direct Offering | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional paid-in capital | $ |
|
|
|
$ 600,000
|
|
|
|
|
|
|
|
|
|
|
|
| Percent of combined offering exercise price per share |
|
|
|
|
|
|
|
125.00%
|
|
|
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
131,472
|
|
|
| Exercise price of warrant | $ / shares |
|
|
|
|
|
|
|
$ 43.75
|
|
|
|
|
|
|
|
| Registered Direct Offering | Common Stock [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable |
|
|
|
|
|
|
|
34,286
|
|
|
|
|
|
|
|
| Registered Direct Offering | Securities Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from offering | $ |
|
|
|
|
|
|
|
$ 15,000,000
|
|
|
|
|
|
|
|
| Registered Direct Offering | Securities Purchase Agreement | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre-funded warrants to purchase |
|
|
|
|
92,857
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering | Securities Purchase Agreement | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, shares |
|
|
|
|
68,604
|
|
|
428,572
|
|
|
|
|
|
|
|
| Registered Direct Offering | Securities Purchase Agreement | Common Stock [Member] | Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pre funded warrant per share | $ / shares |
|
|
|
|
$ 20.6499
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering | Warrant Inducement Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reduction in the exercise prices | $ / shares |
|
$ 38.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering | Warrant Inducement Agreement | April 2024 RDO Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reduction in the exercise prices | $ / shares |
|
$ 22.72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering | Warrant Inducement Agreement | November 2025 Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issue of warrants |
|
904,396
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Registered Direct Offering | Warrant Inducement Agreement | December 2024 RDO Common Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reduction in the exercise prices | $ / shares |
|
$ 22.51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Treasury Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Treasury Stock Common Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
1,458,263
|
|
1,458,263
|
|
|
| SPAC Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repurchase of warrants | $ |
|
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
| SPAC Warrants [Member] | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Repurchase of warrants | $ |
|
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
| Public Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
|
|
|
|
|
|
|
$ 74.38
|
|
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
|
|
|
|
|
|
|
$ 74.38
|
|
|
|
|
|
|
| Public Warrant [Member] | Warrant Transfer Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price per share, warrants | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
| Warrants exercised price | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
|
| Warrants outstanding |
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
28,572
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock shares reserved for future issuance |
|
|
|
|
|
|
|
|
13,446
|
|
|
|
|
|
|
| Public Offering Price Combined |
|
|
|
|
|
|
|
|
125.00%
|
|
|
|
|
|
|
| Warrant [Member] | Registered Direct Offering | Securities Purchase Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders' Equity (Details) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from warrant exercises | $ |
|
|
|
|
$ 17,000,000
|
|
|
|
|
|
|
|
|
|
|